We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canadian Ruling Moves Ranbaxy Closer to Generic Lipitor Launch
Canadian Ruling Moves Ranbaxy Closer to Generic Lipitor Launch
February 6, 2007
A Canadian court’s invalidation of a key patent held by Pfizer could open the door to the manufacturing and marketing of atorvastatin tablets, a generic version of Pfizer’s blockbuster cholesterol-lowering drug, Lipitor.